Healthcare provider profile · identity verified

Kenneth Plowey

Internal Medicine · MONROEVILLE, PA · NPI 1184674012

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	464	129
Amlodipine Besylate	Amlodipine Besylate	421	115
Rosuvastatin Calcium	Rosuvastatin Calcium	389	121
Levothyroxine Sodium	Levothyroxine Sodium	341	84
Lisinopril	Lisinopril	298	79
Losartan Potassium	Losartan Potassium	295	89
Omeprazole	Omeprazole	278	73
Gabapentin	Gabapentin	212	49
Metformin Hcl Er	Metformin Hcl	188	56
Pantoprazole Sodium	Pantoprazole Sodium	185	48
Hydrochlorothiazide	Hydrochlorothiazide	167	46
Famotidine	Famotidine	161	47
Metformin Hcl	Metformin Hcl	156	36
Fluticasone Propionate	Fluticasone Propionate	142	48
Ozempic	Semaglutide	132	20
Simvastatin	Simvastatin	130	39
Metoprolol Tartrate	Metoprolol Tartrate	127	35
Atenolol	Atenolol	120	30
Sertraline Hcl	Sertraline Hcl	116	31
Trazodone Hcl	Trazodone Hcl	115	35
Tamsulosin Hcl	Tamsulosin Hcl	112	37
Meloxicam	Meloxicam	106	34
Montelukast Sodium	Montelukast Sodium	104	28
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	102	26
Clonazepam	Clonazepam	101	24
Tramadol Hcl	Tramadol Hcl	101	32
Zolpidem Tartrate	Zolpidem Tartrate	96	30
Albuterol Sulfate Hfa	Albuterol Sulfate	95	35
Alprazolam	Alprazolam	94	29
Glimepiride	Glimepiride	91	24
Escitalopram Oxalate	Escitalopram Oxalate	87	26
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	87	17
Metoprolol Succinate	Metoprolol Succinate	82	27
Lorazepam	Lorazepam	80	21
Carvedilol	Carvedilol	79	21
Clopidogrel	Clopidogrel Bisulfate	79	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	76	26
Eliquis	Apixaban	75	21
Jardiance	Empagliflozin	69	18
Potassium Chloride	Potassium Chloride	67	17
Duloxetine Hcl	Duloxetine Hcl	62	13
Furosemide	Furosemide	62	22
Ibuprofen	Ibuprofen	62	16
Mounjaro	Tirzepatide	61	15
Methylprednisolone	Methylprednisolone	56	40
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	54	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	54	17
Allopurinol	Allopurinol	53	16
Oxycodone Hcl	Oxycodone Hcl	53	15
Bupropion Hcl Sr	Bupropion Hcl	51	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	15
Buspirone Hcl	Buspirone Hcl	48	11
Propranolol Hcl	Propranolol Hcl	48	suppressed
Labetalol Hcl	Labetalol Hcl	47	suppressed
Mirtazapine	Mirtazapine	46	13
Pravastatin Sodium	Pravastatin Sodium	45	16
Warfarin Sodium	Warfarin Sodium	43	suppressed
Azithromycin	Azithromycin	42	39
Doxycycline Hyclate	Doxycycline Hyclate	40	36
Spironolactone	Spironolactone	40	14
Alendronate Sodium	Alendronate Sodium	39	13
Bupropion Xl	Bupropion Hcl	39	14
Oxybutynin Chloride Er	Oxybutynin Chloride	39	suppressed
Pregabalin	Pregabalin	38	suppressed
Ventolin Hfa	Albuterol Sulfate	38	15
Baclofen	Baclofen	36	suppressed
Citalopram Hbr	Citalopram Hydrobromide	36	12
Synthroid	Levothyroxine Sodium	36	12
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Breo Ellipta	Fluticasone/Vilanterol	34	suppressed
Valacyclovir	Valacyclovir Hcl	33	suppressed
Ezetimibe	Ezetimibe	32	12
Finasteride	Finasteride	32	11
Triamcinolone Acetonide	Triamcinolone Acetonide	31	12
Xarelto	Rivaroxaban	31	suppressed
Carbamazepine	Carbamazepine	30	suppressed
Januvia	Sitagliptin Phosphate	30	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	30	11
Propranolol Hcl Er	Propranolol Hcl	30	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	22
Diclofenac Sodium	Diclofenac Sodium	29	suppressed
Tradjenta	Linagliptin	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	27	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	25
Prednisone	Prednisone	27	25
Chlorhexidine Gluconate	Chlorhexidine Gluconate	26	suppressed
Risperidone	Risperidone	26	suppressed
Amoxicillin	Amoxicillin	25	21
Diazepam	Diazepam	25	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Azelastine Hcl	Azelastine Hcl	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Clotrimazole	Clotrimazole	20	12
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	13
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Ibu	Ibuprofen	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	18	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Lamotrigine	Lamotrigine	18	suppressed
Topiramate	Topiramate	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Glipizide	Glipizide	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	14	12
Dulera	Mometasone/Formoterol	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Naproxen	Naproxen	14	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Cefuroxime	Cefuroxime Axetil	13	suppressed
Cephalexin	Cephalexin	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Cefdinir	Cefdinir	12	11
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Klor-Con M10	Potassium Chloride	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Valsartan	Valsartan	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Felodipine Er	Felodipine	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Unifine Pentips	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error